National Institute for Bioprocessing Research & Training is a private company headquartered in Dublin, Ireland, that operates as a training and research center for biopharmaceutical manufacturing industry.\nThe company says this about itself: The National Institute for Bioprocessing Research and Training (NIBRT) is a global centre of excellence for training and research in bioprocessing. NIBRT serves about 4,000 industry professionals worldwide at its world-class headquarters in Dublin, Ireland. This facility is purpose built to closely replicate a modern bioprocessing plant with state-of-the-art equipment. NIBRT offers a quality training and research experience not previously possible anywhere in the world.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Janssen Pharmaceutica is a pharmaceutical company headquartered in Beerse, Belgium and owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen. In 1961, Janssen Pharmaceutica was purchased by New Jersey-based American corporation Johnson & Johnson, and became part of Johnson & Johnson Pharmaceutical Research and Development (J&J PRD), now renamed to Janssen Research and Development (JRD), which conducts research and development activities related to a wide range of human medical disorders, including mental illness, neurological disorders, anaesthesia and analgesia, gastrointestinal disorders, fungal infection, HIV/AIDS, allergies and cancer. Janssen and Ortho-McNeil Pharmaceutical have been placed in the Ortho-McNeil-Janssen group within Johnson & Johnson Company.

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment businesses; Connected Care businesses; Personal Health businesses; and Other. The Diagnosis and Treatment businesses segment consists systems, smart devices, software and services, powered by AI-enabled informatics-that support precision diagnoses and minimally invasive procedures in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care businesses segment consists Hospital Patient Monitoring, Emergency Care, Sleep & Respiratory Care and Connected Care Informatics. The Personal Health businesses segment consists of Oral Healthcare, Personal Care,Mother and Child Care. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline. The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche. Genentech was founded in 1976 by [Robert Swanson](https://www.crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](https://www.crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.

Nanjing Qizhen Genetic Engineering Co., Ltd., established on 2018-05-10, Business scope includes gene technology,Biotechnology,medical technology,Technological Development of Agricultural Technology,technical consulting,technology transfer,Technical Services;Biological Products Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shanghai Weizhizhuo Biotechnology Co., Ltd., established on 2015-10-19, Business scope includes licensed projects:Import and export;Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:engaged in biotechnology(human stem cells,Except for the development and application of genetic diagnosis and treatment technology)and medical technology(Do not engage in medical activities)technology development in the field,technology transfer,technical consulting,Technical Services,Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,civilian explosives,precursor chemicals),Pharmaceutical Intermediates(In addition to drugs,Hazardous Chemicals)development,Sales,Instrumentation,Sales of Electronics.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Shanghai Saidif Pharmaceutical Technology Co., Ltd., established on 2019-09-05, The scope of business includes engaging in medical technology,Biological Technology(human stem cells,Except for the development and application of genetic diagnosis and treatment technology)technology development in the field,own technology transfer,And provide relevant technical advice and technical services.[Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Shanghai Baoyiren Biomedicine Co., Ltd., established on 2022-11-09, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Engineering and Technology Research and Experimental Development;Medical Research and Experimental Development;Medical Research and Experimental Development(remove human stem cells,Development and application of genetic diagnosis and treatment technology);R&D and application of cell technology;Cosmetics Wholesale;marketing planning;Conference and Exhibition Services;market survey(Does not include foreign investigations);Health Care Services(non-medical);Sales of Class II Medical Devices;Sales of Class I Medical Devices;Health Consulting Services(Does not include medical services);software development;Software outsourcing service;Professional cleaning,to clean,Disinfection service;Information Consulting Service(Not including licensing information consulting services);Business Management Consulting;hospital management;Import and export;Technology Import and Export;Sporting Goods and Equipment Retailing.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Eisai R&D Management Co., Ltd., a subsidiary of Eisai Co., Ltd., is a company headquartered in Bunkyo, Japan. The firm engages in research and development of pharmaceuticals.